dBET1
dBET1 is a hybrid molecule that combines (+)-JQ1 and thalidomide. It induces cereblon-dependent BET protein degradation in vitro (EC50: 430 nM) and induces apoptosis.
| Catalog Number | T4495 |
| Research Area | Chromatin/Epigenetic |
| Molecular Formula | C38H37ClN8O7S |
| CAS# | 1799711-21-9 |
| SMILES | Cc1sc-2c(c1C)C(=N[C@@H](CC(=O)NCCCCNC(=O)COc1cccc3C(=O)N(C4CCC(=O)NC4=O)C(=O)c13)c1nnc(C)n-21)c1ccc(Cl)cc1 |
| Size | 10 mg |
| Supplier Page | https://www.targetmol.com/compound/dBET1 |
| Additional Information | https://www.targetmol.com/datasheet/T4495 |
